/Companies

Enyo Pharma

Lyon, FR · Founded 2014 · 41 employees on LinkedIn · 9 known investors

Find your way into Enyo Pharma

301 people in our graph share verified history with the Enyo Pharma team — schools, employers, funds. One of them is your warm intro.

Gabriela Eccounlockedknows Pietro Scalfaro · together at Sophia Genetics (overlapped)
×3knows the team · via Enyo Pharma
×8knows the team · via Inserm

Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field. This page lists the venture capital and institutional firms that back the company.

Founders & leadership

JVJacky Vonderscher
Jacky VonderscherCo-founder & CEO
LM
Laurène Meyniel-SchicklinFounder, Head of Bioinformatics
BDBenoît de Chassey
Benoît de ChasseyFounder, Head of Drug Discovery PlatformBenoit de Chassey has 20 years of research experience in academia and biotech, and holds an Executive MBA from EM Lyon Business School. He is founder and head of drug discovery platform at Enyo Pharma, a biotechnology company developing therapeutics.
PAPatrice André
Patrice AndréFounder, Medical Advisor
VL
Vincent LotteauFounder, Advisor
JGJean-Jacques Garaud
Jean-Jacques GaraudCo-founder
PSPietro Scalfaro
Pietro ScalfaroSVP Head of Clinical Development & Chief Medical OfficerA physician with experience leading clinical drug development programs, he has worked on projects spanning infectious disease and personalized medicine across multiple therapeutic areas.
RDRaphaël Darteil
Raphaël DarteilSVP Head of non-clinical Development & Profiling
KMKeltoum Medji
Keltoum MedjiVP Finance and Strategic DevelopmentKeltoum Medji is VP Finance and Strategic Development at Enyo Pharma, a biotechnology company focused on drug development. He brings experience in organizational change management, process improvement, and financial controls across M&A, restructuring, and reorganization initiatives.
CMClaudi Miquel
Claudi MiquelVP Legal Affairs & Board Secretary
PLPete Leone
Pete LeoneHead of Business Development & LicensingPete Leone is Head of Business Development & Licensing at Enyo Pharma, a biotechnology company focused on drug development. He has over three decades of experience in biopharmaceutical and medical device companies, including building three venture-backed companies through clinical development and commercialization across multiple therapeutic areas.

Investors · 9

Also in the syndicate · 5

Bpifrance Large VentureInnoBioInserm Transfert InitiativeMorningside Venture InvestmentsSofinnova Private Capital VII

Funding

SEC filings, press & company announcements
  • Undisclosed amountseries B roundJun 2018

    OrbiMed (lead), Andera Partners, Bpifrance Large Venture, InnoBio, Inserm Transfert Initiative, Morningside Venture Investments, Sofinnova Private Capital VII

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Enyo Pharma do?
Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field. This page lists the venture capital and institutional firms that back the company.
Who founded Enyo Pharma?
Enyo Pharma was founded by Jacky Vonderscher, Laurène Meyniel-Schicklin, Benoît de Chassey, Patrice André, Vincent Lotteau, Jean-Jacques Garaud in 2014.
Who are Enyo Pharma's investors?
Enyo Pharma's investors include Andera Partners, OrbiMed, Sofinnova Partners, Bpifrance.
Where is Enyo Pharma headquartered?
Enyo Pharma is headquartered in Lyon, FR.